Japan has improved the health conditions of the people by instituting a universal public insurance system and public health undertakings that have resulted in a long-lived society. Although the prevalence of cancer is increasing in Japan, there are no cancer chemopreventive medicines in Japan to date. We do not have reliable biomarkers for early cancer detection. Moreover, we do not have successful business models for cancer prevention. Thus, it is now a good time to review the current status and future prospects for chemoprevention of cancer with respect to the future development of chemopreventive medicines because several cancer chemoprevention trials have been performed and showed results that can give the feeling of expectation in Japan. In this keynote session, I would like to discuss how to achieve a cancer-free society in the future.
| Date | 10:30-12:30, November 3rd(Thu), 2016 |
|---|---|
| Venue | |
| No. | Fb-651 |
| Organizer | The one dreaming for a cancer preventable future |
Hideki Ishikawa
Chief Director of Japanese Association For Cancer Prevention, Specially-appointed Professor, Department of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine
Yoshitake Yokokura
President, Japan Medical Association
Yoshiyuki Kawakami
Chairperson Industry-Academia-Government Collaboration Subcommittee R&D Committee, The Japan Pharmaceutical Manufacturers Association
Hirokazu Takahashi
Specialist for Cancer Screening, Cancer and Disease Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare
Mariko Takahashi
Senior Staff Writer, The Asahi Shimbun
